home
companies
disclaimer
med safety app
EXFORGE®
Film-coated tablets
scheduling status
S3
registration number
41/7.1.3/0291, 41/7.1.3/0292, 41/7.1.3/0770, 41/7.1.3/0771
What EXFORGE® contains
EXFORGE 5/160 mg: Each film-coated tablet contains 6,94 mg amlodipine besylate (equivalent to 5 mg amlodipine base) and 160 mg valsartan. EXFORGE 10/160 mg: Each film-coated tablet contains 13,87 mg amlodipine besylate (equivalent to 10 mg amlodipine base) and 160 mg valsartan. EXFORGE 5/320 mg: Each film-coated tablet contains 6,94 mg amlodipine besylate (equivalent to 5 mg amlodipine base) and 320 mg valsartan. EXFORGE 10/320 mg: Each film-coated tablet contains 13,87 mg amlodipine besylate (equivalent to 10 mg amlodipine base) and 320 mg valsartan.
other ingredients
Tablet: Microcrystalline cellulose, Crospovidone, Colloidal silicon dioxide, anhydrous, Magnesium stearate. Coating: Hypromellose, Polyethylene glycol 4000, Talc, Titanium dioxide (E171), Iron oxide, yellow (E172), Iron oxide red (E172)(10/160 mg & 5/320 mg &10/320 mg).
Therapeutic classification
A 7.1.3 Vascular medicines – other hypotensives.
Download Patient Info Leaflet
Download Professional Info
© 2026 SAHPRA. ALL RIGHTS RESERVED